Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia (PRP)
A Prospective Double Blind, Placebo Controlled Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia
Sponsor: Universitat Internacional de Catalunya
This NA trial investigates Alopecia and Androgenetic Alopecia and is currently ongoing. Universitat Internacional de Catalunya leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
May 2017 — Jun 2018 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting NA
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universitat Internacional de Catalunya
For direct contact, visit the study record on ClinicalTrials.gov .